LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2–cFLIP–NF-κB signaling axis
Guojin Wu, Yixiang Xu, Robbie D. Schultz, Heyu Chen, Jingjing Xie, Mi Deng, Xiaoye Liu, Xun Gui, Samuel John, Zhigang Lu, Hisashi Arase, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
Topics & Concepts
TRAF2Immune systemMyeloid leukemiaCancer researchNFKB1NF-κBSignal transductionLeukemiaImmunologyMyeloidCell biologyMedicineBiologyTumor necrosis factor alphaTumor necrosis factor receptorGeneticsTranscription factorGeneImmune Cell Function and InteractionNF-κB Signaling PathwaysGenomics, phytochemicals, and oxidative stress